Catalent and Bend (Research) Partner on Oral-Controlled Release Development

June 25, 2012
Outsourcing-Pharma.com

Catalent and Bend Research have joined forces to tackle time and cost restrictions for the complex oral controlled-release development and manufacturing process. Under the deal, Bend will provide its formulation development expertise, whilst Catalent brings its analytical, CMC (chemistry manufacturing controls), solid-state optimisation, as well as its clinical and commercial supply services, to the table.